Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells
The demand for development of new drugs remains on the upward trend because of the large number of patients suffering from intractable diseases for which effective treatment has not been established yet. Recently, several researchers have attempted to apply induced pluripotent stem cell (iPSC) techn...
Main Authors: | Taiki Nakajima, Makoto Ikeya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Regenerative Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320419300148 |
Similar Items
-
Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva
by: Jie Cai, et al.
Published: (2015-12-01) -
Fibrodysplasia ossificans progressiva
by: Chané Smit, et al.
Published: (2023-11-01) -
Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
by: Francesc Ventura, et al.
Published: (2021-02-01) -
Fibrodysplasia ossificans progressiva: Lumps, bumps and biologics
by: Atukorala, I, et al.
Published: (2007) -
Challenges and opportunities for drug repositioning in Fibrodysplasia ossificans progressiva
by: Ventura, F, et al.
Published: (2021)